NO159610C - Fremgangsm te ved rensing av et immuninterferonfrag - Google Patents

Fremgangsm te ved rensing av et immuninterferonfrag

Info

Publication number
NO159610C
NO159610C NO843751A NO843751A NO159610C NO 159610 C NO159610 C NO 159610C NO 843751 A NO843751 A NO 843751A NO 843751 A NO843751 A NO 843751A NO 159610 C NO159610 C NO 159610C
Authority
NO
Norway
Prior art keywords
immun
procedures
interference
cleaning
purification
Prior art date
Application number
NO843751A
Other languages
English (en)
Norwegian (no)
Other versions
NO843751L (no
NO159610B (no
Inventor
Susumu Honda
Hiromu Sugino
Hsiang-Fu Kung
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO843751L publication Critical patent/NO843751L/no
Publication of NO159610B publication Critical patent/NO159610B/no
Publication of NO159610C publication Critical patent/NO159610C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/142—Interferon

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Tires In General (AREA)
  • Detergent Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
NO843751A 1983-09-20 1984-09-19 Fremgangsm te ved rensing av et immuninterferonfrag NO159610C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/534,038 US4604284A (en) 1983-09-20 1983-09-20 Homogeneous immune interferon fragment

Publications (3)

Publication Number Publication Date
NO843751L NO843751L (no) 1985-03-21
NO159610B NO159610B (no) 1988-10-10
NO159610C true NO159610C (no) 1989-01-18

Family

ID=24128463

Family Applications (1)

Application Number Title Priority Date Filing Date
NO843751A NO159610C (no) 1983-09-20 1984-09-19 Fremgangsm te ved rensing av et immuninterferonfrag

Country Status (20)

Country Link
US (1) US4604284A (es)
EP (1) EP0136620B1 (es)
JP (1) JPS6163697A (es)
KR (1) KR850002283A (es)
AT (1) ATE31933T1 (es)
AU (1) AU577314B2 (es)
CA (1) CA1298219C (es)
DE (1) DE3468690D1 (es)
DK (1) DK447684A (es)
ES (1) ES8606885A1 (es)
FI (1) FI843668L (es)
GR (1) GR80403B (es)
HU (1) HU196460B (es)
IL (1) IL72985A0 (es)
MC (1) MC1623A1 (es)
NO (1) NO159610C (es)
NZ (1) NZ209590A (es)
PH (1) PH19646A (es)
PT (1) PT79230B (es)
ZA (1) ZA846549B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US4992271A (en) * 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
JPS60172999A (ja) * 1983-12-20 1985-09-06 Suntory Ltd 新規な塩基性ポリペプチドおよびその製造法
US4758656A (en) * 1983-12-26 1988-07-19 Kyowa Hakko Kogyo Co., Ltd. Novel human interferon-gamma polypeptide derivative
DE3414831A1 (de) * 1984-04-19 1985-10-31 Hoechst Ag, 6230 Frankfurt Herstellung von polypeptiden mit human-gammainterferon-aktivitaet
US4921698A (en) * 1984-05-25 1990-05-01 Asahi Kasei Kogyo Kabushiki Kaisha Polypeptide having gamma-interferon activity lacking amino acids coded by exon 4
IL75302A0 (en) * 1984-06-06 1985-09-29 Takeda Chemical Industries Ltd Novel polypeptide and production thereof
PT84504B (pt) * 1986-03-18 1989-11-10 Research Corp Metodo para a deteccao de haptenos em tecnicas de imunoensaio
US4908432A (en) * 1987-01-09 1990-03-13 New York University Novel polypeptide having gamma-interferon activity
NO162160C (no) * 1987-01-09 1989-11-15 Medi Cult As Serumfritt vekstmedium, samt anvendelse derav.
US5165921A (en) * 1989-01-23 1992-11-24 National Geno Sciences, Inc. Method for treating condyloma acuminatum with interferon
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
WO1998052588A1 (fr) 1997-05-21 1998-11-26 Medion Research Laboratories Inc. Agents therapeutiques adaptes a des affections respiratoires
YU32402A (sh) 1999-11-12 2005-03-15 Maxygen Holdings Ltd. Konjugati gama interferona
JP2003513681A (ja) 1999-11-12 2003-04-15 マキシゲン・ホールディングス・リミテッド インターフェロンガンマ・コンジュゲート
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
US7038015B2 (en) * 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
AU2003239774A1 (en) * 2002-07-03 2004-01-23 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
JP4889505B2 (ja) 2004-02-02 2012-03-07 アンブレツクス・インコーポレイテツド 被修飾されたヒト成長ホルモンポリペプチドおよびこれらの使用
WO2009100255A2 (en) 2008-02-08 2009-08-13 Ambrx, Inc. Modified leptin polypeptides and their uses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
EP0088540A3 (en) * 1982-02-22 1984-10-17 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides
AU571460B2 (en) * 1982-09-27 1988-04-21 Cancer Institute Of Japanese Foundation For Cancer Research Alpha interferon dna, recombinant plasmid, engineered organism and alpha interferon polypeptide
US4432895A (en) * 1982-11-24 1984-02-21 Hoffmann-La Roche Inc. Monomeric interferons
US4485017A (en) * 1982-12-22 1984-11-27 Cetus Corporation Isolation of human interferon by immunosorbent and high performance liquid chromatography
US4476049A (en) * 1983-09-20 1984-10-09 Hoffmann-La Roche Inc. Method for the extraction of immune interferon

Also Published As

Publication number Publication date
PH19646A (en) 1986-06-04
DE3468690D1 (en) 1988-02-18
PT79230A (en) 1984-10-01
PT79230B (en) 1986-11-18
NO843751L (no) 1985-03-21
EP0136620A1 (en) 1985-04-10
ES536027A0 (es) 1986-05-16
AU577314B2 (en) 1988-09-22
IL72985A0 (en) 1984-12-31
MC1623A1 (fr) 1985-09-26
EP0136620B1 (en) 1988-01-13
AU3330384A (en) 1985-03-28
CA1298219C (en) 1992-03-31
HU196460B (en) 1988-11-28
JPS6163697A (ja) 1986-04-01
DK447684A (da) 1985-03-21
ZA846549B (en) 1985-04-24
GR80403B (en) 1985-01-18
ES8606885A1 (es) 1986-05-16
DK447684D0 (da) 1984-09-19
FI843668L (fi) 1985-03-21
US4604284A (en) 1986-08-05
NO159610B (no) 1988-10-10
HUT35288A (en) 1985-06-28
NZ209590A (en) 1989-01-27
ATE31933T1 (de) 1988-01-15
KR850002283A (ko) 1985-05-10
FI843668A0 (fi) 1984-09-19

Similar Documents

Publication Publication Date Title
NO159610C (no) Fremgangsm te ved rensing av et immuninterferonfrag
DK447584D0 (da) Fremgangsmaade til rensning af immuninterferon
ES527414A0 (es) Un metodo de producir una proteina interferon inmune humano
PT76360A (en) Expression processing and secretion of heterologus protein by yeast
PT87332A (pt) Method of purification of product of expression of recombinant ferment
NO178931C (no) Fremgangsmåte for fremstilling av et hovedsakelig rent, terapeutisk aktivt antigent protein, og ekspresjonssystem bestående av et rekombinant virus
BG43182A3 (en) Method for treatment of animal blood and its fractions
SE8704247D0 (sv) Method of treatment
NO883772D0 (no) Kontaktlinserensemiddel og anvendelsesmetode.
PL267231A1 (en) Method of obtaining enzootic cattle leukaemia virus antigen